Table 3.
Chemotherapeutic Agents | Studies on Humans | Studies on Animals | Pregnancy Category * |
---|---|---|---|
Bevacizumab | ND | T | C |
Cetuximab | ND | T | C |
Panitumumab | ND | T* | C |
Sorafenib | ND | T | D |
Imatinib | ND | T | D |
T—teratogenic; T*—data suggesting teratogenicity is not strong enough; ND—no data; Pregnancy category *—U.S. Food and Drug Administration (FDA).